The ARFIP2 Knockout HEK293T Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout population derived from the HEK293T human embryonic kidney cell line, designed for loss-of-function studies of the ARF-interacting protein 2 (ARFIP2). This product provides a genetically heterogeneous pool of cells harboring targeted disruptions in the ARFIP2 gene, enabling robust investigation of ARFIP2-dependent cellular processes without requiring clonal isolation. The polyclonal format preserves biological variability while maintaining a consistent knockout background, making it suitable for high-throughput screening and bulk biochemical analyses. Researchers can interrogate the functional consequences of ARFIP2 depletion across a diverse genetic landscape, reflecting the complexity of native biological systems.
The parental HEK293T cell line is a widely adopted model in molecular and cellular biology, renowned for its epithelial-like adherent morphology, rapid proliferation, and exceptional transfection efficiency. Constitutively expressing the SV40 large T antigen, HEK293T cells enable episomal replication of transfected plasmids, facilitating high-level protein expression and viral production studies. This host provides a versatile platform for probing membrane trafficking and cytoskeletal dynamics, with a well-characterized proteome and transcriptome that streamlines downstream validation experiments. The combination of HEK293T’s technical robustness with targeted ARFIP2 disruption creates a powerful system for dissecting ARF-mediated pathways in a human cellular context.
ARFIP2 functions as a critical scaffolding protein that links activated ARF small GTPases??ARF1, ARF5, and ARF6??to effector molecules controlling vesicle formation and actin polymerization. Upon GTP loading, ARFs recruit ARFIP2 to endosomal and Golgi membranes, where it coordinates clathrin coat assembly via interactions with GGA adaptors (GGA1, GGA2, GGA3) and promotes actin remodeling through Rac1 activation and PIP5K-mediated phosphatidylinositol-4,5-bisphosphate production. This molecular convergence positions ARFIP2 at the interface of membrane fission and cytoskeletal reorganization, regulating endocytic trafficking, Golgi integrity, and cell migratory behavior. Disruption of ARFIP2 expression in this knockout model uncouples ARF signaling from downstream effectors, providing a clean experimental system to dissect the specificity of individual ARF-ARFIP2-effector modules.
In the HEK293T background, ARFIP2 knockout is anticipated to impair clathrin-dependent endocytosis and perturb the actin cytoskeleton, leading to altered cell adhesion, spreading, and migration. Because HEK293T cells exhibit a relatively flat, adherent phenotype with well-defined actin stress fibers, they offer an ideal landscape for visualizing ARFIP2-dependent actin dynamics using phalloidin staining or live-cell imaging. Additionally, the high transfection efficiency of this host allows for rapid rescue experiments with ARFIP2 mutants or truncated constructs, enabling structure-function analyses of its BAR domain and ARF-binding regions. The polyclonal nature of the knockout population ensures that results are not skewed by clonal artifacts, enhancing the reproducibility of functional genomics studies.
This product supports a broad range of applications, from mechanistic dissection of ARF-dependent membrane trafficking to screening efforts for ARFIP2-interacting partners. Researchers can employ immunofluorescence to assess ARFIP2 subcellular localization and its impact on organelle morphology, or co-immunoprecipitation to confirm disrupted interaction networks with ARF1, ARF5, and ARF6. Functional assays such as transferrin uptake quantify endocytic efficiency, while wound healing and transwell migration assays evaluate the role of ARFIP2 in cell motility. Downstream signaling can be probed by phosphorylation status of PAK1 or Rac1 activation pull-downs. For comprehensive technical details or custom experimental support, please contact Ascent Research.
